Free Trial

BioLife Solutions (BLFS) Competitors

BioLife Solutions logo
$24.52 -0.49 (-1.96%)
(As of 09:48 AM ET)

BLFS vs. NTUS, INMD, AXGN, ZYXI, AXNX, NVST, NARI, LIVN, TMDX, and ENOV

Should you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Natus Medical (NTUS), InMode (INMD), AxoGen (AXGN), Zynex (ZYXI), Axonics (AXNX), Envista (NVST), Inari Medical (NARI), LivaNova (LIVN), TransMedics Group (TMDX), and Enovis (ENOV). These companies are all part of the "medical" sector.

BioLife Solutions vs.

Natus Medical (NASDAQ:NTUS) and BioLife Solutions (NASDAQ:BLFS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk, institutional ownership and community ranking.

Natus Medical has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Natus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natus Medical$473.44M2.41$13.18M$0.3789.08
BioLife Solutions$143.27M8.10-$66.43M-$1.06-23.59

Natus Medical has a beta of 0.22, suggesting that its share price is 78% less volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.88, suggesting that its share price is 88% more volatile than the S&P 500.

92.4% of Natus Medical shares are owned by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are owned by institutional investors. 1.2% of Natus Medical shares are owned by insiders. Comparatively, 2.2% of BioLife Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, BioLife Solutions had 28 more articles in the media than Natus Medical. MarketBeat recorded 28 mentions for BioLife Solutions and 0 mentions for Natus Medical. Natus Medical's average media sentiment score of 0.59 beat BioLife Solutions' score of 0.49 indicating that Natus Medical is being referred to more favorably in the media.

Company Overall Sentiment
Natus Medical Positive
BioLife Solutions Neutral

Natus Medical has a net margin of 2.65% compared to BioLife Solutions' net margin of -38.98%. Natus Medical's return on equity of 10.15% beat BioLife Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Natus Medical2.65% 10.15% 7.65%
BioLife Solutions -38.98%-6.61%-5.54%

BioLife Solutions has a consensus price target of $27.50, indicating a potential upside of 9.96%. Given BioLife Solutions' stronger consensus rating and higher possible upside, analysts clearly believe BioLife Solutions is more favorable than Natus Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natus Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BioLife Solutions
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

BioLife Solutions received 169 more outperform votes than Natus Medical when rated by MarketBeat users. However, 83.73% of users gave Natus Medical an outperform vote while only 67.25% of users gave BioLife Solutions an outperform vote.

CompanyUnderperformOutperform
Natus MedicalOutperform Votes
139
83.73%
Underperform Votes
27
16.27%
BioLife SolutionsOutperform Votes
308
67.25%
Underperform Votes
150
32.75%

Summary

Natus Medical and BioLife Solutions tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLFS vs. The Competition

MetricBioLife SolutionsElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$1.16B$3.38B$5.06B$8.82B
Dividend YieldN/A1.65%5.17%4.07%
P/E Ratio-23.5919.00125.9917.81
Price / Sales8.1088.021,180.3874.38
Price / CashN/A46.1733.8232.53
Price / Book3.263.734.684.68
Net Income-$66.43M$92.21M$119.54M$226.08M
7 Day Performance3.73%-5.18%-2.45%-2.04%
1 Month Performance5.84%7.91%-4.06%0.06%
1 Year Performance86.50%20.84%29.86%24.60%

BioLife Solutions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLFS
BioLife Solutions
0.8729 of 5 stars
$24.52
-2.0%
$27.50
+12.2%
+86.5%$1.14B$143.27M-23.13409Analyst Forecast
Insider Trade
Analyst Revision
NTUS
Natus Medical
N/A$32.96
flat
N/A+0.0%$1.14B$473.44M89.081,400Analyst Forecast
INMD
InMode
2.3243 of 5 stars
$18.59
+1.9%
$22.60
+21.6%
-19.3%$1.56B$492.05M9.86480
AXGN
AxoGen
2.7099 of 5 stars
$12.81
-0.7%
$15.00
+17.1%
+113.2%$563.77M$159.01M0.00426
ZYXI
Zynex
3.7354 of 5 stars
$7.89
+0.4%
$14.00
+77.4%
-12.6%$251.30M$184.32M52.401,100
AXNX
Axonics
3.2587 of 5 stars
$70.98
flat
$71.00
+0.0%
N/A$3.63B$366.38M-591.45610News Coverage
NVST
Envista
3.6426 of 5 stars
$20.64
+1.3%
$20.71
+0.3%
-14.3%$3.55B$2.57B-2.6212,800
NARI
Inari Medical
3.2625 of 5 stars
$49.26
+0.5%
$58.89
+19.5%
-15.9%$2.88B$493.63M0.001,300Insider Trade
Positive News
LIVN
LivaNova
4.1794 of 5 stars
$49.75
-0.6%
$69.17
+39.0%
+6.8%$2.70B$1.15B119.172,900
TMDX
TransMedics Group
4.4367 of 5 stars
$78.45
+1.6%
$131.80
+68.0%
+10.5%$2.63B$241.62M82.13210Analyst Forecast
Gap Down
ENOV
Enovis
3.2254 of 5 stars
$45.33
+1.2%
$67.00
+47.8%
-12.3%$2.53B$1.71B0.006,550

Related Companies and Tools


This page (NASDAQ:BLFS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners